Woodline Partners LP Biotechnology

Woodline Partners LP

$11 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
XOMA Xoma Corp	$288M	$2.52 Million 0.02% of portfolio	95,339	Q3 2024 Added 32.03%
TERN Terns Pharmaceuticals, Inc.	$191M	$2.51 Million 0.02% of portfolio	301,224	Q3 2024 Reduced 59.57%
BMEA Biomea Fusion, Inc.	$117M	$2.44 Million 0.02% of portfolio	241,107	Q3 2024 Added 1.98%
FULC Fulcrum Therapeutics, Inc.	$227M	$2.39 Million 0.02% of portfolio	670,807	Q3 2024 Added 33.81%
TARS Tarsus Pharmaceuticals, Inc.	$1.4B	$2.35 Million 0.02% of portfolio	71,569	Q3 2024 New
SCPH Sc Pharmaceuticals Inc.	$93.2M	$2.29 Million 0.02% of portfolio	501,608	Q3 2024 New
NKTR Nektar Therapeutics	$193M	$2.25 Million 0.02% of portfolio	1,731,671	Q3 2024 Added 178.0%
ELDN Eledon Pharmaceuticals, Inc.	$57.2M	$2.1 Million 0.02% of portfolio	842,892	Q3 2024 Added 24.83%
TSHA Taysha Gene Therapies, Inc.	$85.1M	$2.07 Million 0.02% of portfolio	1,027,494	Q3 2024 Added 0.12%
RVNC Revance Therapeutics, Inc.	$212M	$2.05 Million 0.02% of portfolio	797,953	Q3 2024 New
TRVI Trevi Therapeutics, Inc.	$228M	$2.02 Million 0.02% of portfolio	606,227	Q3 2024 New
RLAY Relay Therapeutics, Inc.	$535M	$1.96 Million 0.02% of portfolio	276,904	Q3 2024 Added 1.2%
LXRX Lexicon Pharmaceuticals, Inc.	$145M	$1.9 Million 0.02% of portfolio	1,211,924	Q3 2024 New
THRD Third Harmonic Bio, Inc.	$337M	$1.68 Million 0.02% of portfolio	123,923	Q3 2024 New
IBRX Immunity Bio, Inc.	$969M	$1.63 Million 0.01% of portfolio	439,818	Q3 2024 Added 0.45%
TARA Protara Therapeutics, Inc.	$65.5M	$1.56 Million 0.01% of portfolio	851,567	Q3 2024 Added 751.56%
RGLS Regulus Therapeutics Inc.	$20.6M	$1.49 Million 0.01% of portfolio	948,702	Q3 2024 Added 0.11%
PSTX Poseida Therapeutics, Inc.	$815M	$1.37 Million 0.01% of portfolio	478,861	Q3 2024 New
TYRA Tyra Biosciences, Inc.	$638M	$1.31 Million 0.01% of portfolio	55,866	Q3 2024 Reduced 36.99%
PLRX Pliant Therapeutics, Inc.	$585M	$1.25 Million 0.01% of portfolio	111,660	Q3 2024 Added 7.76%
STOK Stoke Therapeutics, Inc.	$355M	$1.16 Million 0.01% of portfolio	94,382	Q3 2024 Reduced 5.79%
IGMS Igm Biosciences, Inc.	$60.5M	$1.11 Million 0.01% of portfolio	67,259	Q3 2024 Reduced 10.32%
RVPH Reviva Pharmaceuticals Holdings, Inc.	$42.1M	$986,000 0.01% of portfolio	684,805	Q3 2024 Reduced 57.01%
MRSN Mersana Therapeutics, Inc.	$70M	$819,000 0.01% of portfolio	433,552	Q3 2024 Reduced 70.45%
GOSS Gossamer Bio, Inc.	$91.1M	$779,000 0.01% of portfolio	787,288	Q3 2024 Added 0.7%
ATAI Atai Life Sciences N.V.	$249M	$620,000 0.01% of portfolio	535,047	Q3 2024 New
MGNX Macrogenics Inc	$195M	$620,000 0.01% of portfolio	188,711	Q3 2024 Reduced 48.93%
TCRX T Scan Therapeutics, Inc.	$51.5M	$540,000 0.0% of portfolio	108,584	Q3 2024 Reduced 33.58%
VIGL Vigil Neuroscience, Inc.	$50.6M	$490,000 0.0% of portfolio	144,142	Q3 2024 Reduced 30.24%
RAPT Rapt Therapeutics, Inc.	$39.1M	$476,000 0.0% of portfolio	236,990	Q3 2024 Added 42.78%
CTMX Cytom X Therapeutics, Inc.	$58M	$464,000 0.0% of portfolio	393,832	Q3 2024 New
ETNB 89bio, Inc.	$320M	$394,000 0.0% of portfolio	53,347	Q3 2024 New
AVIR Atea Pharmaceuticals, Inc.	$272M	$346,000 0.0% of portfolio	103,358	Q3 2024 New
KRON Kronos Bio, Inc.	$54.5M	$309,000 0.0% of portfolio	309,597	Q3 2024 New
GHRS Gh Research PLC	$446M	$249,000 0.0% of portfolio	37,238	Q3 2024 New
CRBU Caribou Biosciences, Inc.	$99.8M	$238,000 0.0% of portfolio	122,135	Q3 2024 Reduced 48.12%
IMUX Immunic, Inc.	$32.1M	$195,000 0.0% of portfolio	118,652	Q3 2024 New
RZLT Rezolute, Inc.	$194M	$181,000 0.0% of portfolio	37,343	Q3 2024 New
KPTI Karyopharm Therapeutics Inc.	$57.5M	$111,000 0.0% of portfolio	134,112	Q1 2024 Added 14.9%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	986,007	Q3 2024 Added 250.71%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.